Epistemic fault lines in biomedical and social approaches to HIV prevention

Journal of the International AIDS Society

Volumn 14, Issue SUPPL. 2, 2011, Pages

  Adam, Barry D ^a,b  

^a UNIVERSITY OF WINDSOR   (Canada)

^b ONTARIO HIV TREATMENT NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

BIOTECHNOLOGY; BLOOD; CIRCUMCISION; CLINICAL EFFECTIVENESS; CONDOM; CULTURAL ANTHROPOLOGY; DISEASE TRANSMISSION; DRUG USE; HEALTH CARE COST; HETEROSEXUALITY; HIGH RISK POPULATION; HOMOPHOBIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INSURANCE; INTERNET; INTRAVENOUS DRUG ABUSE; KNOWLEDGE; LESBIAN; MALE HOMOSEXUAL; PRIORITY JOURNAL; RACE; REVIEW; RISK MANAGEMENT; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; SOCIAL INTERACTION; SOCIAL NETWORK; SOCIAL STATUS; SOCIAL STRUCTURE; SPERM; TRANSSEXUALISM; UNSAFE SEX; VAGINA SECRETION; VERTICAL TRANSMISSION; VIRUS LOAD; FEMALE; MALE; MEDICAL RESEARCH; METHODOLOGY; PSYCHOLOGICAL ASPECT; SOCIOLOGY;

BIOMEDICAL RESEARCH; FEMALE; HIV INFECTIONS; HUMANS; KNOWLEDGE; MALE; SEXUAL BEHAVIOR; SOCIAL SCIENCES;

EID: 80053330003     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-S2-S2     Document Type: Review

References (77)

1. Tsunami folklore saved islanders Bhaumik S, BBC News 2005 Accessed 31 December 2010
2. Tsunami warning and preparedness,. Orcutt J, Grabowski M, Atwater B, et al. National Academies Press 2010 Accessed 31 December 2010
3. Reconfiguring Truth. Ward S, Lanham, MA, Rowman & Littlefield 1996
4. Reassembling the Social. Latour B, Oxford, Oxford University Press 2005
5. Power/Knowledge. Foucault M, New York, Pantheon 1980
6. Commentaries on the nature of social and cultural research. Mykhalovskiy E, Rosengarten M, Social Theory and Health 2009 7 284 304 10.1057/sth.2009.14
7. Enhancing HIV prevention requires addressing the complex relationship between prevention and treatment. Henderson K, Worth H, Aggleton P, Kippax S, Global Public Health 2009 4 2 117 130 10.1080/17441690802191329 19333804
8. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Montaner J, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR, Lancet 2006 368 531 536 10.1016/S0140-6736(06)69162-9 16890841 (Pubitemid 44142776)
9. Integrating HIV treatment and prevention. Mykhalovskiy E, HIV Treatment and Prevention Technologies in International Perspective London, Palgrave Macmillan, Davis M, Squire C., 2010 61 86
10. Global fund HIV investments specifically targeting most-at-risk populations. Garofalo G, 2011 Accessed 31 December 2010
11. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006. Baral S, Sifakis F, Cleghorn F, Beyrer C, PLOS Medicine 2007 4 12, e339 1901 1911
12. Men who have sex with men and their HIV epidemics in Africa. Van Griensven F, AIDS 2007 21 1361 1362 10.1097/QAD.0b013e328017f868 17545714 (Pubitemid 46883492)
13. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Smith A, Tapsoba P, Peshu N, Sanders E, Jaffe H, Lancet 2009 374 416 422 10.1016/S0140-6736(09)61118-1 19616840
14. The expanding epidemics of HIV type 1 among men who have sex with men in low-and middle-income countries. Beyrer C, Baral S, Walker D, W?rtz A, Johns B, Sifakis F, Epidemiological Review 2010 32 137 151 10.1093/epirev/mxq011
15. Populations at Risk. Public Health Agency of Canada, Public Health Agency of Canada 2010 Accessed 32 December 2010
16. Remedicalizing an epidemic. Nguyen V-K, Bajos N, Dubois-Arber F, OMalley J, Pirkle C, AIDS 2011 25 3 291 293 10.1097/QAD.0b013e3283402c3e 20962615
17. Reasserting the Social in a Biomedical Epidemic. Kippax S, Re-Framing the Social Dimensions of HIV in a Biomedicalised Epidemic Conference London, Overseas Development Institute 2010
18. Coverage of Four Key Populations at the 2010 International AIDS Conference. Ayala G, Beck J, Hebert P, Padua L, Sundararaj M, Oakland, California, Global Forum on MSM and HIV 2011 22
19. HIV treatment as prevention-it works. Editorial, Lancet 2011 377 1719 10.1016/S0140-6736(11)60713-7 21601691
20. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. Fang C-T, Hsu H-M, Twu S-J, Chen MY, Chang YY, Hwang JS, Wang JD, Chuang CY, Division of AIDS and STD, Center for Disease Control, Department of Health, Executive Yuan, Journal of Infectious diseases 2004 190 5 879 885 10.1086/422601 15295691 (Pubitemid 39120963)
21. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. Porco T, Martin J, Page-Shafer K, Cheng A, Charlebois E, Grant RM, Osmond DH, AIDS 2004 18 81 88 10.1097/00002030-200401020-00010 15090833 (Pubitemid 38402321)
22. Treatment as prevention. Challacombe L, Prevention in Focus Canadian AIDS Treatment Information Exchange 2010 Accessed 1 January 2011
23. Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. Neely MN, Benning L, Xu J, Strickler HD, Greenblatt RM, Minkoff H, Young M, Bremer J, Levine AM, Kovacs A, Journal of Acquired Immune Deficiency Syndromes 1999 44 1 38 42
24. Human immunodeficiency virus viral load in blood plasma and semen. Kalichman SC, Di Berto G, Eaton L, Sexually Transmitted Diseases 2008 35 1 55 60 10.1097/OLQ.0b013e318141fe9b 18217225 (Pubitemid 351619353)
25. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. Lorello G, la Porte C, Pilon R, Zhang G, Karnauchow T, MacPherson P, HIV Medicine 2009 10 9 548 554 10.1111/j.1468-1293. 2009.00725.x 19515092
26. Viral blip dynamics during highly active antiretroviral therapy. Di Mascio M, Markowitz M, Louie M, Hogan C, Hurley A, Chung C, Ho DD, Perelson AS, Journal of Virology 2003 77 22 12165 12172 10.1128/JVI.77.22.12165-12172.2003 14581553 (Pubitemid 37339869)
27. Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. Nettles RE, Kieffer TL, Kwon P, Monie D, Han Y, Parsons T, Cofrancesco J Jr, Gallant JE, Quinn TC, Jackson B, Flexner C, Carson K, Ray S, Persaud D, Siliciano RF, Journal of the American Medical Association 2005 293 7 817 829 10.1001/jama.293.7.817 15713771 (Pubitemid 40250365)
28. Infectious syphilis in high-income settings in the 21st century. Fenton KA, Breban R, Vardavas R, Okano JT, Martin T, Aral S, Blower S, Lancet infectious diseases 2008 8 4 244 253 10.1016/S1473-3099(08)70065-3 18353265 (Pubitemid 351391990)
29. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Gardner E, Mckees M, Steiner J, del Rio C, Burman W, Clinical Infectious Diseases 2011 52 6 793 800 10.1093/cid/ciq243 21367734
30. Correlates of unprotected anal sex in HIV positive men attending an HIV/AIDS clinic in Sydney. Begley K, Chan D, Jeganathan S, Batterham M, Smith D, Current HIV Research 2008 6 579 584 10.2174/157016208786501508 18991625
31. Beliefs about treatments for HIV/AIDS and sexual risk behaviors among men who have sex with men, 1997-2006. Kalichman S, Eaton L, White D, Cherry C, Pope H, Cain D, Kalichman MO, Journal of Behavioral Medicine 2007 30 497 503 10.1007/s10865-007-9123-6 17690973 (Pubitemid 350171279)
32. Differences between HIV-positive gay men who frequently, sometimes or never engage in unprotected anal intercourse with serononconcordant casual partners. Rawstorne P, Fogarty A, Crawford J, Prestage G, Grierson J, Grulich A, Kippax S, AIDS Care 2007 19 4 514 522 10.1080/09540120701214961 17453592 (Pubitemid 46598756)
33. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States. Crepaz N, Marks G, Liau A, et al. AIDS 2009 23 1617 1629 10.1097/QAD.0b013e32832effae 19584704
34. Beliefs about transmission risk and vulnerability, treatment adherence, and sexual risk behavior among a sample of HIV-positive men who have sex with men. Joseph H, Flores S, Parsons J, Purcell D, AIDS Care 2010 22 1 29 39 10.1080/09540120903012627 20680858
35. Relation between HIV viral load and infectiousness. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM, Lancet 2008 372 9635 314 320 10.1016/S0140-6736(08)61115-0 18657710 (Pubitemid 352020440)
36. Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Hallett T, Smit C, Garnett G, de Wolf F, Sexually Transmitted Infections 2011 87 17 21 10.1136/sti.2010.042622 20643658
37. Rights language and HIV treatment. Patton C, Rhetoric Society Quarterly 2011 41 3 1 18
38. Sex with older partners is associated with primary HIV infection among men who have sex with men in North Carolina. Hurt C, Matthews D, Calabria M, Green KA, Adimora AA, Golin CE, Hightow-Weidman LB, Journal of Acquired Immune Deficiency Syndromes 2010 54 2 185 189 20057320
39. A major HIV risk factor for young men who have sex with men is sex with older partners. Coburn B, Blower S, Journal of Acquired Immune Deficiency Syndromes 2010 54 113 114 20335817
40. AIDS optimism, condom fatigue, or self esteem? Adam BD, Husbands W, Murray J, Maxwel J, Journal of Sex Research 2005 42 3 238 248 10.1080/00224490509552278 19817037
41. hivstigma.com, an innovative web-supported stigma reduction intervention for gay and bisexual men. Adam BD, Murray J, Ross S, Oliver J, Lincoln S, Rynard V, Health Education Research 2011
42. Antiretroviral Therapy as HIV Prevention. Mayer K, Venkatesh K, American Journal of Public Health 2010 100 10 1867 1876 10.2105/AJPH.2009.184796 20724682
43. How the circumcision solution in Africa will increase HIV infections. van Howe R, Storms M, Journal of Public Health In Africa 2011 2 e4 11 15
44. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Karim Q, Karim S, Frohlich J, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, 5ibeko S, Milsana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D, CAPRISA 004 Trial Group, Science 2010 329 5996 1168 1174 10.1126/science.1193748 20643915
45. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. Grant R, Lama J, Anderson P, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernandez T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LK, Mayer KH, Kallas EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Ronney JF, Jaffe HS, Martinez Al, Burns DN, Glidden DV, iPrEx Study Team, New England Journal of Medicine 2010 363 27 2587 2599 10.1056/NEJMoa1011205 21091279
46. Evaluation of the 100% Condom Programme in Thailand. UNAIDS, Geneva, UNAIDS 2000 47
47. HIV prevalence among populations of men who have sex with men-Thailand, 2003 and 2005. Van Griensven F, Varangrat A, Wimonsate W, et al. MMWR 2006 55 31 844 848 16902394 (Pubitemid 44291123)
48. The Sonagachi project. Jana S, Basu I, Rotheram-Borus M, Newman P, AIDS Education and Prevention 2004 16 5 410 414
49. Harm reduction theory. Friedman S, de Jong W, Rossi D, Touze G, Rockwell R, Des Jarlais DC, Elovich R, International Journal of Drug Policy 2007 18 107 117 10.1016/j.drugpo.2006.11.006 17689353 (Pubitemid 46413733)
50. Effectiveness of sterile needle and syringe programmes. Wodak A, Cooney A, International Journal of Drug Policy 2005 165 31 S44
51. AIDS in the Mind of America. Altman D, Garden City, NY, Doubleday 1986
52. The subject of AIDS. Watney S, AIDS: Social Representations, Social Practices, Aggleton P, Hart G, Davies P. Falmer, 1989
53. Inventing AIDS. Patton C, New York, Routledge 1990
54. Reviving the Tribe. Rofes E, Binghamton, NY, Harrington Park Press 1996
55. Mobilizing around AIDS. Adam BD, In Changing Times Chicago, University of Chicago Press, Levine M, Nardi P, Gagnon J, 1997 23 38
56. Gay and Bisexual Mens Health. Centers for Disease Control and Prevention, Atlanta 2011 Accessed 5 March 2011
57. Social networks, risk-potential networks, health, and disease. Friedman S, Aral S, Journal of Urban Health 2001 78 3 411 418 10.1093/jurban/78.3.411 11564845 (Pubitemid 32852781)
58. Circuits, networks, and HIV risk management. Adam BD, Husbands W, Murray J, Maxwell J, AIDS Education and Prevention 2008 20 5 420 435 10.1521/aeap.2008.20.5.420 18956983
59. Unimagined Community. Thornton R, Berkeley, University of California Press 2008
60. Reflections on 25 years of HIV and AIDS research among drug abusers. Booth R, Des Jarlais D, Friedman S, Journal of Drug Issues 2009 39 1 209 221
61. Episodic sexual transmission of HIV revealed by molecular phylodynamics. Lewis F, Hughes G, Rambaut A, Pozniak A, Brown A, PLOS Medicine 2008 5 3 392 400
62. A public health model for the molecular surveillance of HIV transmission in San Diego, California. Smith D, May S, Tweeten S, Drumright L, Pacold ME, Kosakovsky Pond SL, Pesano RL, Lie YS, Richman DD, Frost SD, Woelk CH, Little SJ, AIDS 2009 23 225 232 10.1097/QAD.0b013e32831d2a81 19098493
63. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Stall R, Mills T, Williamson J, Hart T, Greenwood G, Paul J, Pollack L, Binson D, Osmond D, Catania JA, American Journal of Public Health 2003 93 6 939 942 10.2105/AJPH.93.6.939 12773359 (Pubitemid 38480226)
64. Putting sexuality (back) into HIV/AIDS. Boyce P, Huang Soo Lee M, Jenkins C, Mohamed S, Overs C, Paiva V, Reid E, Tan M, Aggleton P, Global Public Health 2007 2 1 1 34 10.1080/17441690600899362 19280385 (Pubitemid 46738635)
65. Sustaining safe practice. Kippax S, Race K, Social Science & Medicine 2003 57 1 12 10.1016/S0277-9536(02)00303-9 21922346 (Pubitemid 36566515)
66. Positive deviance control-case life history. Friedman S, Mateu-Gelabert P, Sandoval M, Hagan H, Des Jarlais D, BMC Public Health 2008 8 94 10.1186/1471-2458-8-94 18366699 (Pubitemid 351581168)
67. Reframing HIV prevention for gay men in the United States. Halkitis P, American Psychologist 2010 65 8 752 763 21058777
68. Mobilizing collective identity to reduce HIV risk among sex workers in Sonagachi, India. Ghose T, Swendeman D, George S, Chowdhury D, Social Science and Medicine 2008 67 311 320 10.1016/j.socscimed.2008.03.045 18455855 (Pubitemid 351790721)
69. Sex, love, friendship, belonging and place. Rowe M, Dowsett G, Culture, Health & Sexuality 2008 10 4 329 344 10.1080/13691050701843098 21921866 (Pubitemid 351895291)
70. The Rise of a Gay and fesbian Movement. Adam BD, New York, Twayne 1995
71. The Theory of Communicative Action. Habermas J, Boston, Beacon 1987
72. Infectious behaviour. Adam BD, Social Theory and Health 2006 4 168 179 10.1057/palgrave.sth.8700066
73. Effects of the criminalization of HIV transmission in Cuerrier on men reporting unprotected sex with men. Adam BD, Elliott R, Husbands W, Murray J, Maxwell J, Canadian Journal of taw and Society 2008 23 1-2 137 153
74. Method and Measurement in Sociology. Cicourel A, New York, Free Press 1964
75. Wishful thinking? Remien R, Borkowskí T, HIV +Sex Washington, D.C., American Psychological Association, Halkitis P, Gámez C, Wolitski R, 2005 201 215
76. Biomedical and development paradigms in prevention. Wolffers I, Bulletin of the World Health Organization 2000 78 2 267 273 10743300
77. Biomedical HIVprevention - andsocial science. Imrie J, Elford J, Kippax S, Hart G, Lancet 2007 370 July 7 10 11 17617254